JP2012530073A5 - - Google Patents

Download PDF

Info

Publication number
JP2012530073A5
JP2012530073A5 JP2012515290A JP2012515290A JP2012530073A5 JP 2012530073 A5 JP2012530073 A5 JP 2012530073A5 JP 2012515290 A JP2012515290 A JP 2012515290A JP 2012515290 A JP2012515290 A JP 2012515290A JP 2012530073 A5 JP2012530073 A5 JP 2012530073A5
Authority
JP
Japan
Prior art keywords
seq
peptide
compound
peptidomimetic
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012515290A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012530073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2010/000760 external-priority patent/WO2010144968A1/en
Publication of JP2012530073A publication Critical patent/JP2012530073A/ja
Publication of JP2012530073A5 publication Critical patent/JP2012530073A5/ja
Pending legal-status Critical Current

Links

JP2012515290A 2009-06-19 2010-06-18 カゼイン由来のプロテアーゼ阻害ペプチド Pending JP2012530073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2009902841A AU2009902841A0 (en) 2009-06-19 Protease inhibitory peptides
AU2009902841 2009-06-19
PCT/AU2010/000760 WO2010144968A1 (en) 2009-06-19 2010-06-18 Casein derived protease inhibitory peptides

Publications (2)

Publication Number Publication Date
JP2012530073A JP2012530073A (ja) 2012-11-29
JP2012530073A5 true JP2012530073A5 (enExample) 2013-07-04

Family

ID=43355610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012515290A Pending JP2012530073A (ja) 2009-06-19 2010-06-18 カゼイン由来のプロテアーゼ阻害ペプチド

Country Status (8)

Country Link
US (1) US20110104179A1 (enExample)
EP (2) EP2821414A1 (enExample)
JP (1) JP2012530073A (enExample)
KR (1) KR20120027535A (enExample)
CN (1) CN102459321A (enExample)
AU (1) AU2010262763A1 (enExample)
CA (1) CA2765423A1 (enExample)
WO (1) WO2010144968A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007264402B2 (en) 2006-06-27 2012-09-20 Oral Health Australia Pty Ltd Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
WO2008143889A1 (en) 2007-05-14 2008-11-27 Research Foundation Of State University Of New York Induction of a physiological dispersion response in bacterial cells in a biofilm
EP2638905B1 (en) * 2007-07-12 2019-01-16 Oral Health Australia Pty Ltd Biofilm treatment
US20100297179A1 (en) 2007-07-12 2010-11-25 Stuart Geoffrey Dashper Immunology Treatment for Biofilms
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN108840927B (zh) * 2018-06-06 2022-07-29 湖南生达生物科技有限公司 弹性蛋白酶抑制剂lnsp-i及其应用
WO2020167152A1 (en) * 2019-02-15 2020-08-20 RAPAK, Andrzej Marek Inhibitors of cysteine peptidases isolated from natural raw materials and use of the inhibitors in medicine and veterinary medicine
JP6797966B2 (ja) * 2019-04-24 2020-12-09 森永乳業株式会社 胃内酸性プロテアーゼ酵素活性阻害剤、ラクトフェリン組成物の製造方法、及びラクトフェリン組成物
WO2020219062A1 (en) * 2019-04-26 2020-10-29 Colgate-Palmolive Company Methods and compositions to reduce staining for antibacterial oral care compositions
US11013677B2 (en) 2019-04-26 2021-05-25 Colgate-Palmolive Company Methods and compositions to reduce staining for antibacterial oral care compositions
KR20220034563A (ko) * 2020-09-11 2022-03-18 한국생명공학연구원 신규 치주 질환 특이 항체 및 이의 용도
KR102476515B1 (ko) * 2020-09-11 2022-12-12 한국생명공학연구원 치주 질환 특이 항체 및 이의 용도
US20250334583A1 (en) * 2022-05-24 2025-10-30 Shimadzu Corporation Method for preparing sample solution containing neurogranin-related peptide and method for analyzing neurogranin-related peptide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
JP3567012B2 (ja) * 1995-03-28 2004-09-15 雪印乳業株式会社 新規ペプチド及びその利用
AUPP051497A0 (en) * 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
EP1359157A1 (en) * 2002-04-29 2003-11-05 Société des Produits Nestlé S.A. Metallo-proteinase inhibitory agent
EP1568377A1 (en) * 2002-11-29 2005-08-31 Morinaga Milk Industry Co., Ltd. Cysteine protease inhibitor
MXPA06007043A (es) * 2003-12-19 2007-05-23 Univ Melbourne Composicion antimicrobiana.
WO2005081628A2 (en) * 2004-03-01 2005-09-09 Peptera Pharmaceutical Ltd. Casein derived peptides and therapeutic uses thereof
MY162557A (en) * 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection

Similar Documents

Publication Publication Date Title
JP2012530073A5 (enExample)
RU2012140704A (ru) Способ профилактики и/или лечения фиброза и/или помутнения роговицы (варианты), способ получения фармацевтической композиции для профилактики и/или лечения фиброза и/или помутнения роговицы и глазная фармацевтическая композиция
JP2010532765A5 (enExample)
JP2015517488A5 (enExample)
EA201490809A1 (ru) Способы и композиции для лечения неэффективного эритропоэза
ES2682670T3 (es) Lisinas de bacteriófagos de Streptococcus para la detección y tratamiento de bacterias gram positivas
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012008998A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
JP2012523438A5 (enExample)
NZ627372A (en) Clostridium histolyticum enzymes and methods for the use thereof
JP2012530130A5 (enExample)
JP2012529293A5 (enExample)
JP2017526627A5 (enExample)
NZ610620A (en) Inhibitors of apoptosis and uses thereof
ES2955834T3 (es) Variantes de plantaricina nc8alphabeta
WO2011149964A3 (en) Methods for treating or preventing vascular graft failure
US9050323B2 (en) Methods of treating destructive inflammation of the mucous membranes with lactoferrin
JP2018509388A5 (enExample)
AU2025220790A1 (en) Pharmaceutical composition for preventing or treating periodontal disease or luxated teeth
JP2013539776A5 (enExample)
JP2018532748A5 (enExample)
JP2012521366A5 (enExample)
ATE536745T1 (de) Zusammensetzung mit arazym zur prävention und behandlung von krebs
NZ610400A (en) Antimicrobial protein